WallStreetZenWallStreetZen

NASDAQ: PDSB
Pds Biotechnology Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PDSB

Based on 2 analysts offering 12 month price targets for Pds Biotechnology Corp

Min Forecast
$7.00+469.11%
Avg Forecast
$10.00+713.01%
Max Forecast
$13.00+956.91%

Should I buy or sell PDSB stock?

Based on 2 analysts offering ratings for Pds Biotechnology Corp.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PDSB's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates PDSB as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their PDSB stock forecasts and price targets.

PDSB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-27
lockedlocked$00.00+00.00%2024-11-25

1 of 1

Forecast return on equity

Is PDSB forecast to generate an efficient return?

Company
-316.5%
Industry
142.24%
Market
81.01%
PDSB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PDSB forecast to generate an efficient return on assets?

Company
-132.61%
Industry
36.11%
PDSB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PDSB earnings per share forecast

What is PDSB's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.14
Avg 2 year Forecast
-$1.16
Avg 3 year Forecast
-$1.29

PDSB revenue forecast

What is PDSB's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$3.8M
Avg 2 year Forecast
$106.8M
Avg 3 year Forecast
$237.4M

PDSB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PDSB$1.23$10.00+713.01%Strong Buy
PMVP$1.07$5.00+367.29%Buy
RPTX$1.28$4.50+251.56%Strong Buy
SER$5.78$11.00+90.31%Strong Buy
KRON$0.88$1.00+13.64%Hold
View Top Biotech Stocks

Pds Biotechnology Stock Forecast FAQ

Is Pds Biotechnology Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: PDSB) stock is to Strong Buy PDSB stock.

Out of 2 analysts, 1 (50%) are recommending PDSB as a Strong Buy, 1 (50%) are recommending PDSB as a Buy, 0 (0%) are recommending PDSB as a Hold, 0 (0%) are recommending PDSB as a Sell, and 0 (0%) are recommending PDSB as a Strong Sell.

If you're new to stock investing, here's how to buy Pds Biotechnology stock.

What is PDSB's earnings growth forecast for 2025-2027?

(NASDAQ: PDSB) Pds Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.73%.

Pds Biotechnology's earnings in 2025 is -$37,610,384.On average, 2 Wall Street analysts forecast PDSB's earnings for 2025 to be -$51,524,291, with the lowest PDSB earnings forecast at -$62,192,316, and the highest PDSB earnings forecast at -$40,856,266. On average, 2 Wall Street analysts forecast PDSB's earnings for 2026 to be -$52,659,187, with the lowest PDSB earnings forecast at -$62,192,316, and the highest PDSB earnings forecast at -$43,126,058.

In 2027, PDSB is forecast to generate -$58,560,648 in earnings, with the lowest earnings forecast at -$69,001,694 and the highest earnings forecast at -$48,119,602.

What is PDSB's revenue growth forecast for 2028-2030?

(NASDAQ: PDSB) Pds Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 63.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.2%.

Pds Biotechnology's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast PDSB's revenue for 2028 to be $172,504,234, with the lowest PDSB revenue forecast at $172,504,234, and the highest PDSB revenue forecast at $172,504,234. On average, 1 Wall Street analysts forecast PDSB's revenue for 2029 to be $4,846,007,094, with the lowest PDSB revenue forecast at $4,846,007,094, and the highest PDSB revenue forecast at $4,846,007,094.

In 2030, PDSB is forecast to generate $10,778,790,861 in revenue, with the lowest revenue forecast at $10,778,790,861 and the highest revenue forecast at $10,778,790,861.

What is PDSB's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PDSB) forecast ROA is -132.61%, which is lower than the forecast US Biotechnology industry average of 36.11%.

What is PDSB's Price Target?

According to 2 Wall Street analysts that have issued a 1 year PDSB price target, the average PDSB price target is $10.00, with the highest PDSB stock price forecast at $13.00 and the lowest PDSB stock price forecast at $7.00.

On average, Wall Street analysts predict that Pds Biotechnology's share price could reach $10.00 by Mar 27, 2026. The average Pds Biotechnology stock price prediction forecasts a potential upside of 713.01% from the current PDSB share price of $1.23.

What is PDSB's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: PDSB) Pds Biotechnology's current Earnings Per Share (EPS) is -$1.03. On average, analysts forecast that PDSB's EPS will be -$1.14 for 2025, with the lowest EPS forecast at -$1.37, and the highest EPS forecast at -$0.90. On average, analysts forecast that PDSB's EPS will be -$1.16 for 2026, with the lowest EPS forecast at -$1.37, and the highest EPS forecast at -$0.95. In 2027, PDSB's EPS is forecast to hit -$1.29 (min: -$1.52, max: -$1.06).

What is PDSB's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PDSB) forecast ROE is -316.5%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.